ASHPOfficial

Clinical Conversations (CE): Vaccine Preventable Diseases: Shingles

In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Futures Podcast Series: Navigating the AI Summit with Ben Michaels

UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Leadership: Advocacy 101: How to Talk About Advocacy within and Outside the Profession

This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Advocating for Impact: Bipartisan Senate Proposal to Address Drug Shortages

Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Futures Podcast Series: Expert precepting perspectives with Michelle McCarthy and Andrea Haron

ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Futures Podcast Series: Compounding Education with Mike Ganio

ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Role of the Medication Safety Officer

This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Leadership: SPPL: The Journey Towards Developing Future Pharmacy Leaders Starts Today

This podcast features a conversation about engaging the next generation of pharmacy leaders.  As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations.      

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drug Pricing’s New Frontier – The Inflation Reduction Act

This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you.  

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Futures Podcast Series: More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity with Kristi Kelley and Morgan Stewart

ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.